Clinical trial · Interventional
Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
Patient Satisfaction With Placement of Implantable Venous Access Devices
NCT01098643CI-TRIAL-00026743terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): not enough pts for available to reach goal
Summary
Brief summary (as posted)
RATIONALE: Gathering information about patients with solid tumors who have implantable venous access devices may help doctors learn more about patient satisfaction. PURPOSE: This phase I trial is studying satisfaction with placement of implantable venous access devices in patients with solid tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| computer-assisted intervention | Other | — | UNRESOLVED |
| medical chart review | Other | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
| survey administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall satisfaction with port placement
- timeFrame
- n/a - study closed
Secondary outcomes (3)
- measure
- Frequency of complications
- measure
- Frequency of port failure
- measure
- Need for removal of device
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosis of a solid tumor malignancy * No hematological malignancy * Patient at the Vanderbilt Oncology Clinic * Has undergone placement of a subcutaneous, single-lumen venous-access device within the past 6 months * No patients who have had ≥ 2 venous-access devices placed by ≥ 1 department PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics * Not currently undergoing preparation for or process of stem cell transplantation
References
Publications (0)
Data not yet available
No reference posted for this study.